Disclaimer :
This Product Image is the Property of Arvantis Pharmaceuticals. Using this Product Image Without Prior Permission is Prohibited and Ignoring this Request May Lead to Legal Consequences.
Composition
Nitroglycerin Controlled Release Tablets 2.6 mg
Description
NITROARV-G 2.6 (Nitroglycerin Controlled Release Tablets 2.6 mg) is an anti-anginal medicine used for the prevention and long-term management of angina pectoris (chest pain) associated with coronary artery disease. Its controlled-release formulation provides sustained delivery of nitroglycerin, helping relax blood vessels, improve blood flow to the heart, and reduce the heart's workload. Manufactured under stringent quality standards, Arvantis Pharmaceuticals ensures safe, effective, and reliable tablets with consistent therapeutic performance. These tablets are ideal for hospital supply, PCD Pharma Franchise, third-party manufacturing, institutional procurement, and bulk distribution across Delhi and India.
Enter your details to start WhatsApp chat
Tablets
Capsules
Softgels
Syrups & Susp.
Injectables
Drops
Cream-lotions
Dry Syrups
Others
